Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF).

scientific article published in August 2010

Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF). is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/10799893.2010.489227
P698PubMed publication ID20536315
P5875ResearchGate publication ID44661877

P50authorDimitrios SpandidosQ18701325
Katerina D SamaraQ79712629
P2093author name stringKaterina M Antoniou
George A Margaritopoulos
Giannoula Soufla
Nikolaos M Siafakas
Dimitra Kappou
Emmanouil Symvoulakis
Evi Vassalou
Rena Lymbouridou
P2860cites work???Q28215495
Survival of cancer cells is maintained by EGFR independent of its kinase activityQ24309274
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancersQ27851457
Mutations of the BRAF gene in human cancerQ27860760
MYCL1, FHIT, SPARC, p16(INK4) and TP53 genes associated to lung cancer in idiopathic pulmonary fibrosisQ28217248
Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivoQ28240836
Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosisQ28260133
Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosisQ28278590
The biochemistry of apoptosisQ29547741
Lung cancer in never smokers--a different diseaseQ29615414
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung diseaseQ30442380
Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor.Q34333813
The epidemiology of interstitial lung disease and its association with lung cancerQ35875981
The prognosis of cryptogenic fibrosing alveolitisQ36442446
Cryptogenic fibrosing alveolitis and lung cancerQ36463491
Evolving concepts of apoptosis in idiopathic pulmonary fibrosisQ36493966
Techniques used in studies of age-related DNA methylation changesQ36521045
A translational view of the molecular pathogenesis of lung cancerQ36780534
Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosisQ36951842
RAS: target for cancer therapyQ37271795
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancerQ37376100
Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosisQ37591872
Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.Q40184040
Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis. A review of Japanese casesQ40431691
Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosisQ42810857
Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial resultsQ43223134
Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosisQ47680928
Down-regulation of K-ras and H-ras in human brain gliomas.Q48779053
Lung cancer associated with usual interstitial pneumonia.Q51009716
The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.Q52927020
Expression analysis of angiogenic growth factors and biological axis CXCL12/CXCR4 axis in idiopathic pulmonary fibrosis.Q54446707
P433issue4
P921main subjectpulmonary fibrosisQ32446
idiopathic pulmonary fibrosisQ2290446
P304page(s)262-269
P577publication date2010-08-01
P1433published inJournal of Receptors and Signal TransductionQ6295837
P1476titleExpression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF)
P478volume30

Reverse relations

cites work (P2860)
Q92624635A network-based pathway-extending approach using DNA methylation and gene expression data to identify altered pathways
Q37421028Atorvastatin attenuates bleomycin-induced pulmonary fibrosis via suppressing iNOS expression and the CTGF (CCN2)/ERK signaling pathway
Q58129865Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis
Q54231908Dasatinib attenuated bleomycin-induced pulmonary fibrosis in mice.
Q37341340Differential telomerase expression in idiopathic pulmonary fibrosis and non-small cell lung cancer.
Q42282467Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite score
Q38187149Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanisms.
Q47651544Elongation factor-2 kinase acts downstream of p38 MAPK to regulate proliferation, apoptosis and autophagy in human lung fibroblasts
Q35830712Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis
Q37707603Inhibition of the αvβ6 integrin leads to limited alteration of TGF-α-induced pulmonary fibrosis
Q41617768Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-β1 mediated Smad2/3 and ERK1/2 activation
Q56243543Lung cancer and interstitial lung disease: a literature review
Q35889180MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation
Q92564621TGFβ1-Smad canonical and -Erk noncanonical pathways participate in interleukin-17-induced epithelial-mesenchymal transition in Sjögren's syndrome
Q39114742Thrombin induces epithelial-mesenchymal transition via PAR-1, PKC, and ERK1/2 pathways in A549 cells
Q36480367p70 ribosomal S6 kinase regulates subpleural fibrosis following transforming growth factor-α expression in the lung

Search more.